Earnings · US stocks

Capricor Therapeutics, Inc. (CAPR) earnings

Capricor Therapeutics, Inc. published its quarterly report on 2026-11-10. The stock moved +7.44% in the 3 trading days after the report.

Report
quarterly report
Published
2026-11-10
Result
Bad / loss
Open earnings in Wave Radar

Stock move after the report

Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.

AfterReturnvs index
1 day+26.49%—
3 days+7.44%—

Report history

Over the last 8 reports, EPS beat the consensus estimate in 1 of them. The stock rose in the 3 trading days after 6 of 8 reports (average +14.86%).

PublishedEPSEPS surprise3 days after30 days after30d vs index
2026-11-10-0.73-78.59%+7.44%——
2026-08-13-0.70-21.62%+68.17%+98.57%+99.41%
2026-03-12-0.62-12.43%-6.67%+5.54%-1.65%
2025-11-10-0.54+0.26%+3.78%+419.78%+418.83%
2025-08-11-0.57-19.37%-0.51%-21.36%-25.65%
2025-05-13-0.53-66.67%+29.32%+39.45%+35.19%
2025-03-19-0.16-70.21%+8.67%+4.26%+5.78%
2024-11-13-0.38-12.59%+8.69%-16.74%-16.37%

The last 8 reported quarters. Moves count trading days from the first tradeable session after the report; "30d vs index" is the excess return over the market index.

Stock valuations: CAPR · Stock news: CAPR

How to read this

Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.

Figures are generated automatically from Wave Radar's published market data and refresh after each market close.